Encell Co. Ltd.
KOE: 456070.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Hong-bae Jeon
- Employees
- 112
- Headquarters
- Seoul, South Korea
- IPO year
- 2024
- Market cap
- ₩153B
- Website
- http://www.encellinc.com
Loading 456070…
Loading profile data…Frequently asked questions about 456070
What does Encell Co. Ltd. (456070.KQ) do?
Encell Co. Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It provides customized pharmaceutical development services, from early development stage to approval stage. The company was founded in February 2018 and is headquartered in Seoul, South Korea.
Where does 456070.KQ trade?
Encell Co. Ltd. (456070.KQ) trades on the KOSDAQ.
What sector is 456070.KQ in?
Encell Co. Ltd. (456070.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Encell Co. Ltd.?
Hong-bae Jeon is the chief executive officer of Encell Co. Ltd. (456070.KQ).
Where is Encell Co. Ltd. headquartered?
Encell Co. Ltd. is headquartered in South Korea.
Does 456070.KQ pay a dividend?
Encell Co. Ltd. (456070.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 456070.KQ go public?
Encell Co. Ltd. (456070.KQ) completed its initial public offering in 2024.